Wearable Sensor Study for Estimating Heart Pumping Function
Tests a wearable sensor to estimate heart pumping function in adults with cardiotoxicity.
Plain-language title generated from the registry record
Registry title: Novel On-body Evaluation of Cardiac Health for Oncology
Key facts
- Where
- Albany, Clearwater, Germantown, Golden, Houma, Jacksonville, Littleton, Naperville, Richmond, Rochester, and Yardley, United StatesSee the 11 sites
Where in United States
- Capital Cardiology AssociatesAlbany, United StatesNo longer taking part
- Clearwater Cardiovascular ConsultantsClearwater, United StatesNo longer taking part
- Stern Cardiovascular CenterGermantown, United StatesNo longer taking part
- Colorado Heart and VascularGolden, United StatesNo longer taking part
- Cardiovascular Institute of the SouthHouma, United StatesNo longer taking part
- First Coast Cardiovascular InstituteJacksonville, United StatesNo longer taking part
- South Denver CardiologyLittleton, United StatesNo longer taking part
- Midwest Cardiovascular InstituteNaperville, United StatesNo longer taking part
- Virginia Commonwealth UniversityRichmond, United StatesNo longer taking part
- Strong Memorial HospitalRochester, United StatesNo longer taking part
- Cardiology Consultants of PhiladelphiaYardley, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Skribe Medical
- Trial code
- NCT07158450
- Record updated
- 5 October 2026
- Original description
The goal of this study is to develop a wearable sensor system that can estimate left ventricular ejection fraction (LVEF), which is a measurement of the heart's function.Read full original descriptionShow less
Evaluation of Wearable Sensor-Based Estimation of Left Ventricular Ejection Fraction (LVEF) - Pilot Study
The goal of this study is to develop a wearable sensor system that can estimate left ventricular ejection fraction (LVEF), which is a measurement of the heart's function.
Inclusion: Undergoing an echocardiogram irrespective of participation in this study; Willing and able to provide informed consent prior to any study-related activity.
Exclusion: Have a documented allergy to potential tissue contacting system materials; Have any condition that would cause inaccurate TTE measurements.